Funding Opportunities Specific to COVID-19

This page contains a listing of active and expired funding opportunities specific to Coronavirus Disease 2019 (COVID-19).

On This Page:

Active Funding Opportunities
Expired Funding Opportunities

Active Funding Opportunities

Title	Notice Number	Organization(s)	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy	NOT-GM-21-021	NIGMS, SGMRO	Mar 1, 2021	May 1, 2021	333
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy	NOT-GM-21-021	NIGMS, SGMRO	Mar 1, 2021	May 1, 2021	333
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs	NOT-TR-21-022	NCATS	Feb 26, 2021	Aug 17, 2024	333
Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration	NOT-AG-21-016	NIA	Feb 26, 2021	May 8, 2023	R01, R21, R03
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2	NOT-GM-21-019	NIGMS	Feb 25, 2021	Dec 16, 2021	333
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2	NOT-GM-21-019	NIGMS	Feb 25, 2021	Dec 16, 2021	333
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies	NOT-GM-21-031	NIGMS	Feb 18, 2021	Apr 1, 2021	333
Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders	NOT-DA-21-019	NIDA	Feb 10, 2021	Sep 8, 2024	R01, R03, R21
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)	RFA-AA-21-003	NIAAA	Feb 5, 2021	Apr 15, 2021	R03
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)	RFA-AA-21-003	NIAAA	Feb 5, 2021	Apr 15, 2021	R03
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)	RFA-AA-21-002	NIAAA	Feb 5, 2021	Apr 15, 2021	R01
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)	RFA-AA-21-002	NIAAA	Feb 5, 2021	Apr 15, 2021	R01
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)	RFA-AA-21-004	NIAAA	Feb 5, 2021	Apr 15, 2021	R21
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)	RFA-AA-21-004	NIAAA	Feb 5, 2021	Apr 15, 2021	R21
Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19	NOT-DA-21-017	NIDA	Feb 4, 2021	Sep 8, 2024	R01, R03, R21
Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI)	NOT-AI-21-008	NIAID	Feb 4, 2021	Jan 8, 2023	R01, R21
Notice of Special Interest (NOSI): Urgent Competitive Revisions and Administrative Supplements for Research at NIMHD Research Centers in Minority Institutions (RCMI U54s) on SARS-CoV-2 Vaccine Hesitancy, Uptake, and Implementation	NOT-MD-21-012	NIMHD	Feb 4, 2021	May 4, 2021	333
Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders	NOT-DA-21-018	NIDA	Feb 3, 2021	Sep 8, 2024	R01, R03, R21
Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control	NOT-CA-21-033	NCI	Feb 3, 2021	Apr 1, 2021	333
Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs	NOT-TR-21-017	NCATS	Feb 3, 2021	Aug 17, 2024	333
Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)	NOT-DE-21-001	NIDCR	Jan 26, 2021	May 8, 2023	R01, R21
Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)	NOT-AG-21-015	NIA	Jan 26, 2021	May 8, 2023	R01, R03, R21, U19, P01, R21/R33
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection	NOT-DA-21-011	NIDA	Jan 26, 2021	Sep 8, 2024	R01, R03, R21
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)	RFA-AI-20-078	NIAID, NIEHS	Jan 12, 2021	Jun 5, 2021	U19
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)	RFA-AI-20-077	NIAID, NIEHS	Jan 12, 2021	Jun 5, 2021	U01
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases	NOT-AR-21-012	NIAMS	Jan 5, 2021	Nov 19, 2021	R01, R21
Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research	NOT-MH-21-120	NIMH	Dec 23, 2020	Jun 2, 2023	333
Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities	NOT-MD-21-008	NIMHD, NCI, NHLBI, NIAAA, NIAID, NIAMS, NIDCR, NIMH, NINR, OBSSR, ODP, ORWH	Dec 17, 2020	Jan 8, 2022	R01
Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs	NOT-TR-21-011	NCATS	Dec 17, 2020	Jun 2, 2021	333
Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects	NOT-AI-21-002	NIAID	Nov 10, 2020	Jun 12, 2021	P01
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection	NOT-DA-20-084	NIDA	Oct 27, 2020	Sep 8, 2024	R01, R03, R21
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)	NOT-TR-21-006	NCATS	Oct 23, 2020	Mar 17, 2021	UH2, U34, U01
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)	NOT-TR-21-006	NCATS	Oct 23, 2020	Mar 17, 2021	UH2, U34, U01
Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)	NOT-HL-20-814	NHLBI	Sep 15, 2020	Jul 6, 2024	R01
Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2	NOT-AI-20-065	NIAID	Aug 13, 2020	Mar 15, 2021	U01
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities	NOT-MD-20-025	NIMHD, NCI, NIDA, NLM, ODP, OBSSR, NIMH, NIAMS	Aug 13, 2020	May 8, 2023	R01
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)	PAR-20-256	NIAID	Jul 13, 2020	Jul 8, 2021	S10
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	NOT-AI-20-059	NIAID	Jul 6, 2020	Jul 2, 2021	333
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project	NOT-OD-20-129	NIH, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIAID, NIAMS, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, ORIP	Jun 25, 2020	Jul 13, 2021	333
Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders	NOT-DC-20-008	NIDCD	Jun 4, 2020	Sep 8, 2022	R01, R21, R41/R42, R43/R44
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System	NOT-NS-20-051	NINDS	Apr 30, 2020	Apr 15, 2021	333
Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA	NOT-AA-20-011	NIAAA	Apr 16, 2020	Apr 16, 2021	333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences	NOT-OD-20-097	OBSSR, NCCIH, NCI, NHGRI, NHLBI, NIAAA, NICHD, NIDDK, NIEHS, NINR, ODP, ORWH	Apr 13, 2020	Apr 1, 2021	333
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)	NOT-ES-20-020	NIEHS	Apr 10, 2020	May 4, 2021	333, R21
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities	NOT-MD-20-019	NIMHD, NIAAA, NIMH, ODP	Apr 9, 2020	May 1, 2021	333
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus	NOT-TR-20-017	NCATS	Apr 9, 2020	Jan 26, 2022	333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus	NOT-MH-20-047	NIMH, NIAAA, ODP	Apr 9, 2020	Apr 16, 2021	333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus	NOT-TR-20-016	NCATS	Apr 9, 2020	Jan 26, 2022	333
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)	NOT-ES-20-015	NIEHS	Apr 8, 2020	May 4, 2021	333, R21
Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)	NOT-AG-20-022	NIAAA, NIMH	Apr 2, 2020	May 1, 2021	333
RESCINDED - Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	NOT-AI-20-031	NIAID	Mar 27, 2020	Apr 5, 2021	R03, R21, 333, R01, R43/R44, R41/R42
Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need	NOT-TR-20-011	NCATS	Mar 24, 2020	Jul 10, 2021	333, U01, R21, U54
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus	NOT-DA-20-047	NIDA	Mar 19, 2020	Mar 31, 2021	333
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)	PA-20-135	NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSC	Mar 10, 2020	Sep 8, 2025	333
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)	RFA-OD-19-029	ORWH, NCCIH, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIDA, NIDCR, NIEHS, NIMH, NINR	Sep 27, 2019	Nov 27, 2021	R01

Expired Funding Opportunities

Title	Notice Number	Organization(s)	Release Date	Expiration Date	Activity Code(s)
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed)	NOT-AA-21-003	NIAAA	Jan 27, 2021	Feb 28, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed)	NOT-AA-21-003	NIAAA	Jan 27, 2021	Feb 28, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trials Not Allowed)	NOT-AA-21-002	NIAAA	Jan 27, 2021	Feb 3, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed)	NOT-AA-21-001	NIAAA	Jan 27, 2021	Feb 28, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed)	NOT-AA-21-001	NIAAA	Jan 27, 2021	Feb 28, 2021
Notice of Special Interest (NOSI): Urgent Competitive Revisions for Research on Critical Threats to Public Health in Large-Scale Population Cohorts	NOT-HG-21-020	NHGRI	Dec 10, 2020	Jan 16, 2021	333
Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities	NOT-MD-21-007	NIMHD	Dec 7, 2020	Dec 31, 2020
Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad)	NOT-OD-21-035	NIH, NIDCR, NHLBI	Nov 25, 2020	Dec 5, 2020	333
Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)	NOT-OD-21-020	NIH, NLM, NIEHS, NIAMS, NIDCR, OBSSR, NIGMS, NHLBI, NCI, NIAAA, NINR, NCATS, ORWH, NHGRI, FIC, NCCIH, NIMH, THRO, NIDA, NINDS, NEI, NIMHD, NIAID, NIA, FDA, NIBIB, NIDCD, NICHD, NIDDK	Nov 17, 2020	Mar 5, 2021	333
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities	NOT-ES-21-002	NIEHS	Nov 17, 2020	Dec 30, 2020	333
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities	NOT-ES-21-002	NIEHS	Nov 17, 2020	Dec 30, 2020	333
Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)	RFA-OD-20-023	NIH, FIC, NCATS, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIMHD	Aug 6, 2020	Oct 1, 2020	R61/R33
Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional)	RFA-OD-20-022	NIH, NIA, NIDCD, ORWH, NICHD, NLM, NINR, NINDS, NIDCR	Aug 6, 2020	Sep 16, 2020	U01
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)	RFA-OD-20-021	NIH, NIAAA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR	Aug 6, 2020	Sep 19, 2020	R42
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)	RFA-OD-20-020	NIH, NIAAA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR	Aug 6, 2020	Sep 19, 2020	R44
Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)	RFA-OD-20-019	NIH, NIAAA, NIA, NCCIH, NIDCD, NIDDK, NIEHS, NIGMS, NICHD, NIMHD, NLM, NINR, NCATS, OBSSR, NHLBI, NIDCR, NIDA	Aug 6, 2020	Oct 1, 2020	U24
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)	RFA-OD-20-018	NIH, NIA, NCI, RM, NCATS, NHLBI, NIDCR, NIDA, NHGRI	Aug 6, 2020	Sep 19, 2020	U18
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)	RFA-OD-20-018	NIH, NIA, NCI, RM, NCATS, NHLBI, NIDCR, NIDA, NHGRI	Aug 6, 2020	Sep 19, 2020	U18
Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)	RFA-OD-20-017	NIH, NIAAA, NIA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR	Aug 6, 2020	Sep 19, 2020	U18
Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)	RFA-OD-20-016	NIH, NIAAA, NIDDK, NIGMS, NIMHD, NLM, NINR, OBSSR, NIDCR, NIDA	Aug 6, 2020	Oct 1, 2020	R01
Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed)	RFA-OD-20-015	NIH, NIEHS, NIGMS, NLM, NIDA	Aug 6, 2020	Sep 16, 2020	U01
Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)	RFA-OD-20-014	NIH, NIAAA, NIA, NCCIH, NCI, NICHD	Aug 6, 2020	Sep 16, 2020	U01
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool	NOT-OD-20-152	NIH, NIA, NIDCD, ORWH, NICHD, NINR, NINDS, NIDCR	Aug 6, 2020	Sep 16, 2020	333
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19).	NOT-OD-20-159	NIH, NLM	Aug 6, 2020	Aug 22, 2020	333
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)	RFA-TR-20-003	NCATS	Aug 5, 2020	Jan 24, 2021	U01
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-rad Initiative	NOT-OD-20-144	NIH, NIDCD	Jul 10, 2020	Aug 6, 2020
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)	RFA-DK-20-021	NIDDK	Jul 10, 2020	Dec 17, 2020	R01
Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19)	NOT-CA-20-082	NCI	Jul 6, 2020	Aug 15, 2020	333
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)	PAR-20-243	NIMH, NCCIH, NEI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIMHD, NINR, OBSSR, ODP, ORWH	Jun 25, 2020	Mar 3, 2021	R01
Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers	NOT-CA-20-077	NCI	Jun 25, 2020	Jul 31, 2020
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)	PAR-20-237	NIMHD, NIDCD, NIMH, ODP, NINR, NIA, SGMRO, NIDDK, NIEHS, NICHD, NCATS, ORWH, NIAAA, NCCIH, NIDA, NEI, NIDCR	Jun 17, 2020	Dec 2, 2020	R01
Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need	NOT-TR-20-029	NCATS	Jun 15, 2020	Nov 11, 2020	333
NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)	PAR-20-234	NIA	Jun 15, 2020	Feb 2, 2021	R01
Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	NOT-OD-20-121	NIH, NIDCR, NICHD, NCI, NCATS, NEI, NHLBI, NIAID, NIAMS, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIAAA, NIDA, NIMHD, ORWH, OBSSR, NLM, SGMRO, THRO, NIA, NCCIH, ODP	Jun 12, 2020	Aug 8, 2020	333
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	NOT-OD-20-120	NIH, NIAID, NIBIB, NIDCR, NIMHD, NICHD, NIAMS, FIC, NCI, NCATS, NCCIH, NEI, NHLBI, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIAAA, NIA, NIDCD, NIDA, ORWH, OBSSR, ODP, NLM, SGMRO, THRO	Jun 12, 2020	Sep 9, 2020	333
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	NOT-OD-20-119	NIH, NICHD, FIC, NCI, NCATS, NCCIH, NEI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIA, NIAAA, NIDA, NIMHD, ORWH, ODP, NLM, SGMRO, THRO, NIDCD, OBSSR	Jun 12, 2020	Sep 9, 2020	333
Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)	RFA-OD-20-013	NIH, NCI, NIAMS, NIA, NICHD, FIC, NCATS, NCCIH, NEI, NHLBI, NIBIB, NIDCR, NIEHS, NIGMS, NHGRI, NIMH, NINR, NIDCD, NIDA, NIMHD, ORWH, OBSSR, NLM, SGMRO, THRO, ODP	Jun 12, 2020	Aug 8, 2020	U24
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)	RFA-CA-20-038	NCI, NIAID	Jun 5, 2020	Jul 23, 2020	U54
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)	RFA-CA-20-039	NCI, NIAID	Jun 5, 2020	Jul 23, 2020	U01
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations	NOT-MD-20-022	NIMHD, ORWH, NCATS, NCCIH, NEI, NHLBI, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, OBSSR, ODP	Jun 5, 2020	Dec 30, 2020	333
Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19	NOT-MH-20-053	NIMH, NCATS, NCCIH, NEI, NHLBI, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NINR, OBSSR, ODP, ORWH	Jun 5, 2020	Dec 30, 2020	333
Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional)	NOT-MH-20-058	NIMH, NIAAA, NIA, NCCIH, NIDCD, NICHD, NINR, OBSSR, ODP, NIDCR, NIDA, NEI	Jun 4, 2020	Jun 26, 2020
Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)	NOT-MD-20-023	NIMHD, NIDCD, OBSSR, NIDA, NINR, ODP, NCCIH, NIMH, NIDCR, NIEHS, NIA, NICHD, ORWH	Jun 3, 2020	Jun 17, 2020
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives	NOT-OD-20-112	NIH	May 29, 2020	Jun 26, 2020
Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) related Research	NOT-OD-20-107	NIH	May 27, 2020	Jun 30, 2020	333
Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19)	NOT-AT-20-012	NCCIH	May 26, 2020	Aug 18, 2020	333
NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional)	RFA-RM-20-020	RMOD	May 21, 2020	Oct 1, 2020	R01
NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional)	RFA-RM-20-021	RMOD	May 21, 2020	Sep 5, 2020	DP5
Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	NOT-AI-20-051	NIAID	May 19, 2020	Sep 8, 2020	R03,R43/R44,R41/R42
Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence	NOT-CA-20-066	NCI	May 15, 2020	Jun 5, 2020
Notice of Special Interest (NOSI):? Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR	NOT-DE-20-022	NIDCR, ORWH	May 5, 2020	Nov 3, 2020	333
Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network	NOT-DE-20-023	NIDCR	May 1, 2020	Nov 3, 2020	X01
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)	PAR-20-177	NIAID	Apr 30, 2020	Aug 14, 2020	R21
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)	PAR-20-178	NIAID	Apr 30, 2020	Aug 14, 2020	R01
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials	NOT-HL-20-782	NHLBI	Apr 27, 2020	Oct 6, 2020	333
Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21)	NOT-LM-20-011	NLM	Apr 27, 2020	Jun 17, 2020	R21
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	NOT-RM-20-015	RMOD	Apr 27, 2020	Jun 20, 2020	333
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs	NOT-TR-20-028	NCATS	Apr 23, 2020	Nov 11, 2020	333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19)	NOT-LM-20-010	NLM	Apr 16, 2020	Jun 2, 2020	333
Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)	NOT-EB-20-007	NIBIB	Apr 10, 2020	Aug 29, 2020	R01,R21,R03
Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19	NOT-GM-20-027	NIGMS	Apr 10, 2020	May 6, 2020	333
NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)	NOT-ES-20-017	NIEHS	Apr 10, 2020	Apr 25, 2020	333
Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)	NOT-EB-20-006	NIBIB	Apr 10, 2020	Sep 6, 2020	R41/R42,R43/R44
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)	NOT-EB-20-008	NIBIB	Apr 10, 2020	Aug 29, 2020	333
Notice of Special Interestregarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2	NOT-NS-20-046	NINDS	Apr 10, 2020	May 9, 2020	333
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission	NOT-DK-20-020	NIDDK	Apr 9, 2020	Jun 2, 2020	333
Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)	NOT-CA-20-043	NCI	Apr 9, 2020	Jun 26, 2020	333
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK	NOT-DK-20-018	NIDDK	Apr 9, 2020	Jun 2, 2020	333
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19)	NOT-DC-20-004	NIDCD	Apr 9, 2020	Jun 2, 2020	333
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)	NOT-AT-20-011	NCCIH, NIA, NIAAA, ODP	Apr 9, 2020	Oct 7, 2020	333
Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)	NOT-CA-20-042	NCI	Apr 9, 2020	Jun 26, 2020	333
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus	NOT-HG-20-030	NHGRI	Mar 31, 2020	May 16, 2020	333
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)	NOT-TR-20-012	NCATS	Mar 27, 2020	Oct 17, 2020	UH2,U01,U34
RESCINDED - Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)	NOT-ES-20-014	NIEHS	Mar 27, 2020	Apr 25, 2020	333
RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	NOT-AI-20-034	NIAID	Mar 25, 2020	Jul 6, 2020	333
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2	NOT-GM-20-025	NIGMS	Mar 25, 2020	Feb 6, 2021	333
RESCINDED - Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)	NOT-HL-20-757	NHLBI	Mar 17, 2020	May 15, 2020	333
RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)	NOT-AI-20-030	NIAID, NIGMS	Feb 6, 2020	Apr 8, 2020	333
Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)	NOT-OD-20-048	ORWH, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD	Dec 13, 2019	Jan 26, 2021	333